ImmuneSpec
Company

ImmuneSpec

Biotechnology Research Niel, Antwerpen, Be 14 employees
Employees
14
Contacts
1
Emails
1

ImmuneSpec Overview

Headquarters
Niel, Antwerpen, Be
Industry
Biotechnology Research
Employees
14
Founded
2023
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ImmuneSpec

ImmuneSpec is a next-generation immunopeptidomics platform that delivers unmatched precision in identifying peptides presented by MHC molecules. Powered by advanced mass spectrometry, ImmuneSpec provides deep, unbiased insight into immune presentation—enabling the development of safer, more effective biotherapeutics. The platform supports early detection of immunogenic regions in biologics, reducing immune risk and guiding safer drug design. ImmuneSpec also accelerates target discovery by revealing rare neoepitopes and validates constructs by confirming that designed epitopes are effectively presented. With rapid turnaround, high-throughput capability, and rigorous quality control, ImmuneSpec empowers researchers to advance transformative therapies—from personalized medicine to next-generation vaccines and immunotherapies.

ImmuneSpec Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

ImmuneSpec Org Chart

Sample employees and titles
Name Title Contact
Elise Pepermans CEO & Co-founder Immunespec - We're
View
Barbara Vercruyssen Director Finance and Operations
Email
Thibault Jonckheere Looking for My Next Entrepreneurial
View
Ellen Boelen Director, Business Development
View

Employees by Management Level

Director 2 profiles
Executive 1 profile
Individual contributor 1 profile

Compare Similar Companies to ImmuneSpec